1. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD8+ T‐cell recognition of a synthetic epitope formed by t‐butyl modification. Issue 3 (March 2015) Authors: Reid, Reiss A.; Redman, James E.; Rizkallah, Pierre; Fegan, Chris; Pepper, Chris; Man, Stephen Journal: Immunology Issue: Volume 144:Issue 3(2015:Mar.) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL. (8th November 2019) Authors: Elston, Lauren; Fegan, Chris; Hills, Robert; Hashimdeen, Shaikh S.; Walsby, Elisabeth; Henley, Peter; Pepper, Chris; Man, Stephen Journal: British journal of haematology Issue: Volume 188:Number 6(2020) Page Start: 872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is venetoclax a new wonder drug in CLL?. (11th March 2019) Authors: Fegan, Chris; Pepper, Chris Journal: British journal of haematology Issue: Volume 185:Number 4(2019) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract. (1st March 2022) Authors: Saud, Zack; Ponsford, Mark; Bentley, Kirsten; Cole, Jade M; Pandey, Manish; Jolles, Stephen; Fegan, Chris; Humphreys, Ian; Wise, Matt P; Stanton, Richard Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NF-κκB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia. (September 2009) Authors: Pepper, Chris; Hewamana, Saman; Brennan, Paul; Fegan, Chris Journal: Future oncology Issue: Volume 5:Number 7(2009) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Telomere analysis to predict chronic lymphocytic leukemia outcome: a STELA test to change clinical practice?. Issue 6 (December 2014) Authors: Pepper, Chris; Baird, Duncan; Fegan, Chris Journal: Expert review of hematology Issue: Volume 7:Issue 6(2014) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. (3rd July 2014) Authors: Lin, Thet Thet; Norris, Kevin; Heppel, Nicole H.; Pratt, Guy; Allan, James M.; Allsup, David J.; Bailey, James; Cawkwell, Lynn; Hills, Robert; Grimstead, Julia W.; Jones, Rhiannon E.; Britt‐Compton, Bethan; Fegan, Chris; Baird, Duncan M.; Pepper, Chris Journal: British journal of haematology Issue: Volume 167:Number 2(2014:Oct.) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Telomere length is a critical determinant for survival in multiple myeloma. (24th March 2017) Authors: Hyatt, Sam; Jones, Rhiannon E.; Heppel, Nicole H.; Grimstead, Julia W.; Fegan, Chris; Jackson, Graham H.; Hills, Robert; Allan, James M.; Pratt, Guy; Pepper, Chris; Baird, Duncan M. Journal: British journal of haematology Issue: Volume 178:Number 1(2017) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Telomere length is an independent prognostic marker in MDS but not in de novo AML. (9th May 2017) Authors: Williams, Jenna; Heppel, Nicole H.; Britt‐Compton, Bethan; Grimstead, Julia W.; Jones, Rhiannon E.; Tauro, Sudhir; Bowen, David T.; Knapper, Steven; Groves, Michael; Hills, Robert K.; Pepper, Chris; Baird, Duncan M.; Fegan, Chris Journal: British journal of haematology Issue: Volume 178:Number 2(2017) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗